Literature DB >> 15883047

Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I.

Marita Sporstøl1, German Tapia, Lene Malerød, Seyed Ali Mousavi, Trond Berg.   

Abstract

Pregnane X receptor (PXR) is the molecular target for a wide variety of endogenous and xenobiotic compounds. It regulates the expression of genes central to the detoxification (cytochrome P-450 enzymes) and excretion (xenobiotic transporters) of potentially harmful compounds. The aim of the present investigation was to determine the role of PXR in regulation of high-density lipoprotein (HDL) cholesterol metabolism by studying its impact on ATP-binding cassette transporter A1 (ABCA1) and scavenger receptor class B type I (SR-BI) expression in hepatocytes. ABCA1 and SR-BI are major factors in the exchange of cholesterol between cells and HDL. Expression analyses were performed using Western blotting and quantitative real time RT-PCR. Luciferase reporter gene assays were used to measure promoter activities. Total cholesterol was measured enzymatically after lipid extraction (Folch's method). The expression of ABCA1 and SR-BI was inhibited by the PXR activators rifampicin and lithocholic acid (LCA) in HepG2 cells and pregnenolone 16alpha-carbonitrile (PCN) in primary rat hepatocytes. Thus, PXR appears to be a regulator of hepatic cholesterol transport by inhibiting genes central to cholesterol uptake (SR-BI) and efflux (ABCA1).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883047     DOI: 10.1016/j.bbrc.2005.04.071

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Sterol regulation of metabolism, homeostasis, and development.

Authors:  Joshua Wollam; Adam Antebi
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

2.  Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events.

Authors:  J Svärd; F Blanco; D Nevin; D Fayne; F Mulcahy; M Hennessy; J P Spiers
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 3.  Novel functions of PXR in cardiometabolic disease.

Authors:  Changcheng Zhou
Journal:  Biochim Biophys Acta       Date:  2016-02-26

4.  Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis.

Authors:  Taesik Gwag; Zhaojie Meng; Yipeng Sui; Robert N Helsley; Se-Hyung Park; Shuxia Wang; Richard N Greenberg; Changcheng Zhou
Journal:  J Hepatol       Date:  2019-01-21       Impact factor: 25.083

Review 5.  SR-B1: A Unique Multifunctional Receptor for Cholesterol Influx and Efflux.

Authors:  Wen-Jun Shen; Salman Azhar; Fredric B Kraemer
Journal:  Annu Rev Physiol       Date:  2017-11-10       Impact factor: 19.318

6.  Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?

Authors:  Sibylle Neuhoff; Geoffrey T Tucker
Journal:  Br J Clin Pharmacol       Date:  2018-02-21       Impact factor: 4.335

Review 7.  Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function.

Authors:  Wen-Jun Shen; Shailendra Asthana; Fredric B Kraemer; Salman Azhar
Journal:  J Lipid Res       Date:  2018-05-02       Impact factor: 5.922

8.  Chlordecone altered hepatic disposition of [14C]cholesterol and plasma cholesterol distribution but not SR-BI or ABCG8 proteins in livers of C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-02-06       Impact factor: 4.219

9.  Chlordecone, a mixed pregnane X receptor (PXR) and estrogen receptor alpha (ERalpha) agonist, alters cholesterol homeostasis and lipoprotein metabolism in C57BL/6 mice.

Authors:  Junga Lee; Richard C Scheri; Yuan Zhang; Lawrence R Curtis
Journal:  Toxicol Appl Pharmacol       Date:  2008-08-26       Impact factor: 4.219

10.  Regulation of tissue-specific carboxylesterase expression by pregnane x receptor and constitutive androstane receptor.

Authors:  Chenshu Xu; Xinkun Wang; Jeff L Staudinger
Journal:  Drug Metab Dispos       Date:  2009-04-09       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.